Psychiatry & Neurology Doctors in Leominster, MA Accepting Medicare

16 Psychiatry & Neurology doctors found. Showing 1 - 16

Jie Yin, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Suite 209, Leominster, MA 01453 Phone: 978-466-2411    Fax: 978-537-9211

Lloyd M. Alderson, M.D. Psychiatry & Neurology - Neurology Medicare: May Accept Medicare Assignments Practice Location: 50 Memorial Dr, Suite 211, Leominster, MA 01453 Phone: 978-466-2411    Fax: 978-537-9211

Dr. John Franken Aney, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Suite 206, Leominster, MA 01453 Phone: 978-840-8808    Fax: 978-840-1661

Christopher C Kennedy, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Leominster, MA 01453 Phone: 978-840-8808

Dr. Michael Edwad Gotthelf I, M.D. Psychiatry & Neurology - Neurology Medicare: Not Enrolled in Medicare Practice Location: 50 Memorial Dr, Suite 211, Leominster, MA 01453 Phone: 978-537-3355    Fax: 978-537-9211

Dr. Ramteen Rezai, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1069 Central St, Tak Center For Mental Health, Leominster, MA 01453 Phone: 978-728-4957    Fax: 978-798-1366

Leah Grodin Richler, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 40 Spruce St, Leominster, MA 01453 Phone: 978-537-6116    Fax: 978-534-3294

Daron C Massey, MD Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 100 Erdman Way, Leominster, MA 01453 Phone: 978-466-8316

Dr. Tatyana P Shteinlukht, M.D. Psychiatry & Neurology - Geriatric Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 60 Hospital Rd, Leominster, MA 01453 Phone: 978-466-2000

Dr. Julianne M Miller, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 45 Summer St, Leominster, MA 01453 Phone: 978-534-6116    Fax: 978-534-3294

Dr. Bruce P Hurter, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 45 Summer St, Leominster, MA 01453 Phone: 978-534-6116

Eric C. Kosinski, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Suite 206, Leominster, MA 01453 Phone: 978-840-0400    Fax: 978-840-0404

James Leslie Kahn, M.D. Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 21 Wilder Ln, Leominster, MA 01453 Phone: 978-342-1668

Dr. Carlin Brandon Lucky, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1069 Central St, Leominster, MA 01453 Phone: 978-728-4957    Fax: 978-798-1366

Sarah L Calnan, D.O. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 196 Mechanic St, Leominster, MA 01453 Phone: 508-860-2222

Shabbir A Abbasi, M.D. Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 50 Memorial Dr, Leominster, MA 01453 Phone: 978-466-2411    Fax: 978-466-2418

News Archive

UCSF presents update of Phase 2 clinical trial of Oncophage cancer vaccine at SNO 2009

Antigenics today announced that the Brain Tumor Research Center at the University of California, San Francisco (UCSF), has presented an update on a Phase 2 clinical trial of Oncophage (vitespen) for recurrent high grade glioma (brain cancer) at the 2009 Joint Meeting of SNO (Society for Neuro-Oncology) and AANS/CNS Section on Tumors 2009 in New Orleans, LA.

Researchers find many postmarket safety events after FDA approval of new drugs

How often are safety concerns raised about a drug after it's been approved by the FDA? Nicholas Downing, MD, of the Department of Medicine at Brigham and Women's Hospital, and colleagues have found that for drugs approved between 2001 and 2010, nearly 1 in 3 had a postmarket safety event.

Genetic risk score can be used to determine risk of developing prostate cancer

Some racial and ethnic groups suffer relatively more often, and fare worse, from common ailments compared to others. Prostate cancer is one disease where such health disparities occur: risk for the disease is about 75 percent higher, and prostate cancer is more than twice as deadly, in Blacks compared to whites.

Hyperion HPN-100 phase III pivotal study for urea cycle disorders meets primary endpoint

Hyperion Therapeutics, Inc. today announced that the Company's phase III pivotal study of glycerol phenylbutyrate (HPN-100), an investigational drug for the treatment of urea cycle disorders (UCDs), met its primary endpoint. The non-inferiority study, conducted under a Special Protocol Assessment (SPA) granted by the U.S. Food and Drug Administration (FDA) in June 2009, evaluated the ammonia control of glycerol phenylbutyrate as compared to sodium phenylbutyrate (BUPHENYL®).

Prenatal THC and CBD exposure impairs offspring's ability to respond to fluoxetine

Scientists at Indiana University have found that significant amounts of the two main components of cannabis, THC and CBD, enter the embryonic brain of mice in utero and impair the mice's ability as adults to respond to fluoxetine, a drug commonly used to treat anxiety and depression and known by the brand name Prozac.

Read more Medical News

› Verified 3 days ago